Peripheral nerve injury is known to upregulate the rapidly repriming Na v 1.3 sodium channel within first-order spinal sensory neurons. In this study, we hypothesized that (1) after peripheral nerve injury, second-order dorsal horn neurons abnormally express Na v 1.3, which (2) contributes to the responsiveness of these dorsal horn neurons and to pain-related behaviors. To test these hypotheses, adult rats underwent chronic constriction injury (CCI) of the sciatic nerve. Ten days after CCI, allodynia and hyperalgesia were evident. In situ hybridization, quantitative reverse transcription-PCR, and immunocytochemical analysis revealed upregulation of Na v 1.3 in dorsal horn nociceptive neurons but not in astrocytes or microglia, and unit recordings demonstrated hyperresponsiveness of dorsal horn sensory neurons. Intrathecal antisense oligodeoxynucleotides targeting Na v 1.3 decreased the expression of Na v 1.3 mRNA and protein, reduced the hyperresponsiveness of dorsal horn neurons, and attenuated pain-related behaviors after CCI, all of which returned after cessation of antisense delivery. These results demonstrate for the first time that sodium channel expression is altered within higher-order spinal sensory neurons after peripheral nerve injury and suggest a link between misexpression of the Na v 1.3 sodium channel and central mechanisms that contribute to neuropathic pain after peripheral nerve injury.
Introduction
Injury of peripheral nerves can result in the development of a chronic neuropathic pain syndrome associated with hyperresponsiveness of sensory neurons within the dorsal root ganglion (DRG) (Wall and Devor, 1983; Study and Kral, 1996) and the spinal cord dorsal horn (Woolf, 1983; Sotgiu et al., 1992; Laird and Bennett, 1993) .
Voltage-gated sodium channels underlie action potential generation and play a critical role in electrical signaling between neurons. The TTX-sensitive (TTX-S) Na v 1.3 sodium channel is normally expressed at relatively high levels in the rat embryonic nervous system but is barely detectable in the adult DRG or spinal cord (Beckh et al., 1989; Waxman et al., 1994; Felts et al., 1997; Hains et al., 2002) . However, expression of Na v 1.3 is upregulated within DRG neurons after their axotomy by sciatic nerve transection (Waxman et al., 1994; Black et al., 1999) and after chronic constriction injury (CCI) of the sciatic nerve in adult rats (DibHajj et al., 1999) . This is functionally important, because Na v 1.3 produces a rapidly repriming TTX-S current that permits neuronal firing at higher-than-normal frequencies within DRG neurons (Cummins and Waxman, 1997; Cummins et al., 2001) . To date, however, the question of whether peripheral nerve injury triggers changes in sodium channel expression within higherorder sensory neurons has not been examined.
In this study, we hypothesized that upregulated expression of Na v 1.3 occurs in second-order dorsal horn sensory neurons after peripheral nerve injury and that Na v 1.3 contributes to hyperresponsiveness of these neurons and to behavioral allodynia and hyperalgesia. To test this hypothesis, we examined Na v 1.3 expression in dorsal horn neurons and, using a targeted antisense (AS) oligodeoxynucleotide (ODN) knockdown strategy, examined the functional contribution of Na v 1.3 to the hyperresponsiveness of dorsal horn neurons and pain-related behaviors after CCI.
Materials and Methods
Animal care. Experiments were performed in accordance with National Institutes of Health guidelines for the care and use of laboratory animals; all animal protocols were approved by the Yale University Institutional Animal Use Committee. Adult male Sprague Dawley rats (200 -225 gm) were used for this study. Animals were housed under a 12 hr light/dark cycle in a pathogen-free area with ad libitum access to water and food.
Chronic constriction injury. Rats (n ϭ 63) were deeply anesthetized with ketamine/xylazine (80/5 mg/kg, i.p.), and the left sciatic nerve was exposed at the mid-thigh level by blunt dissection of the biceps femoris.
For CCI (n ϭ 48), four chromic gut (4-0) ligatures were tied loosely around the nerve ϳ1 mm apart, proximal to its trifurcation, as described by Bennett and Xie (1988) . For sham surgery (n ϭ 15), the sciatic nerve was isolated but not ligated. After CCI or sham surgery, the overlying muscles and skin were closed in layers with 4-0 silk sutures and staples, respectively, and the animal recovered on a 30°C heating pad. Postoperative treatments included saline (2.0 cc, s.c.) for rehydration and enrofloxacin (0.3 cc; 22.7 mg/ml, s.c.). After surgery, animals were maintained under the same conditions and fed ad libitum.
ODN synthesis and delivery. Seven days after CCI, animals (n ϭ 50) were anesthetized with ketamine/xylazine (80/5 mg/kg, i.p.), and a sterile premeasured 32 gauge intrathecal catheter (ReCathCo, Allison Park, PA) was introduced through a slit in the atlanto-occipital membrane and threaded to the lumbar enlargement for antisense administration, as described in detail previously (Hains et al., 2003c) . Four days after catheter placement (day 11 after CCI), intrathecal administration of an AS ODN sequence corresponding to the translation initiation site of Na v 1.3 (5Ј-CAGTGCCTGGGCCATCTTTTC-3Ј) (CCI plus 1.3 AS; n ϭ 20) or its mismatch (MM) (5Ј-CGATCGCGTGCGCTATCTTCT-3Ј) (CCI plus 1.3 MM; n ϭ 13) was initiated. A search of the GenBank nucleotide sequence database for short conserved sequences using BLAST algorithms and the Na v 1.3 AS ODN sequence as a query returned only matches from rat, mouse, and human Na v 1.3. However, manual alignment of the sequence from all of the Na v 1 channel sequences showed that the AS ODN sequence of Na v 1.3 is identical at 17/21 to Na v 1.1 and Na v 1.2 and identical at 14/21 to Na v 1.6. However, the identical residues were separated by mismatches, such that the longest contiguous stretch of the sequence was 7 for Na v 1.1 and Na v 1.6, and 11 for Na v 1.2. Thus, it is not likely that the Na v 1.3 AS can form a stable duplex with channel sequences other than Na v 1.3. For 4 d, 45 g/5 l twice daily of either AS or MM in artificial CSF (aCSF; in mM: 1.3 CaCl 2 -2 H 2 O, 2.6 KCl, 0.9 MgCl, 21.0 NaHCO 3 , 2.5 Na 2 HPO 4 -7 H 2 O, and 125.0 NaCl; prepared in sterile H 2 O) was injected followed by a 10 l aCSF flush. On day 4, Cy3-tagged AS or MM was delivered in the same manner to a subset of these animals. This confirmed uptake of AS by neurons within laminas I-V. In a subset of CCI plus 1.3 AS animals (n ϭ 8), AS injections were stopped after 4 d (on day 14 after CCI), and outcome measures continued for another 3 d. A separate group of injured animals (CCI; n ϭ 15) underwent intrathecal injection of aCSF only.
In situ hybridization. Ten days after CCI or sham surgery, tissue was collected from the ipsilateral and contralateral DRG (n ϭ 6 animals/ group) and spinal cord lumbar enlargement (n ϭ 6 animals/group) (L3-L5) of rats after perfusion with 4% paraformaldehyde PBS and fixation in 30% sucrose. Twelve micrometer transverse cryosections (n ϭ 4 sections/animal) from each treatment group were processed for detection of Na v 1.3 mRNA as described previously , with incubation in 4% paraformaldehyde increased to 12 min and permeabilization with proteinase K reduced to 6 min. Digoxigenin-labeled antisense and sense riboprobes for Na v 1.3 (nucleotides 6335-6813; GenBank accession number Y00766) were synthesized as described previously. Sense riboprobes yielded no signal on in situ hybridization (data not shown).
Quantitative reverse transcription-PCR. Ten days after CCI or sham surgery, fresh tissue was collected from the ipsilateral and contralateral DRG and L3-L5 of the ipsilateral and contralateral sides of the spinal cord (n ϭ 5-8 animals/group) and flash frozen. Total tissue RNA was extracted using RNeasy minicolumns (Qiagen, Valencia, CA), and purified RNA was treated with RNase-free DNase I and repurified using an RNeasy mini-column. First-strand cDNA was reverse-transcribed using 5 l of purified total RNA, 1 mM random hexamer primer (Roche, Indianapolis, IN), 40 U of SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA), and 40 U of RNase inhibitor (Roche). The buffer consisted of (in mM) 50 Tris-HCl, pH 8.3, 75 KCl, 3 MgCl 2 , 10 DTT, and 5 deoxyNTP. The reaction proceeded at 37°C for 90 min, continued at 42°C for 30 min, and was terminated by heating to 95°C for 5 min. A parallel reaction omitting reverse transcriptase was performed to demonstrate the absence of contaminating genomic DNA.
Expression of Na v 1.3 mRNA was quantified using the relative standard curve method of PCR using methods described previously (Hains et al., 2003c) . 18S ribosomal RNA (rRNA) was used as an endogenous control to normalize expression levels. Na v 1.3 cDNA was obtained from human embryonic kidney 293 cells stably transfected with an Na v 1.3 construct (Cummins et al., 2001) . Standards and unknowns were amplified in quadruplets. Primer and probe sequences for the Na v 1.3 target were designed using Primer Express software (Applied Biosystems, Foster City, CA) according to the specifications of the TaqMan protocol. Sequences for the forward primer, reverse primer, and probe are as follows: 5Ј-AGGACAATGTCCAGAAGGGTAC-3Ј, 5Ј-AGTAGTC-CTGAGTCATGAGTCGAAAC-3Ј, and 5Ј-TGGGACGAAACC-CCAACTACGGCTACAC-3Ј, respectively. The amplicon comprises nucleotides 1442-1556 of the Na v 1.3 gene. Standard curves for sodium channel primer-probe sets and 18S rRNA endogenous control (rRNA) were constructed from the respective mean critical threshold (C T ) value, and the equation describing the curve was derived using Sequence Detection System software, version 1.6.3 (Applied Biosystems).
Immunocytochemistry. Tissue was collected in the same manner as for in situ hybridization for both ipsilateral and contralateral DRG and lumbar spinal cord (n ϭ 6 animals/group) 10 d after sham or CCI surgery. For detection of Na v 1.3 protein, cryosections (n ϭ 4 sections/animal) were mounted, and slides were incubated at room temperature in the following: (1) blocking solution (PBS containing 5% NGS, 2% BSA, 0.1% Triton X-100, and 0.02% sodium azide) for 30 min, (2) subtypespecific primary antibody raised in rabbit against Na v 1.3 (16153) overnight in blocking solution, (3) PBS, six times for 5 min each, (4) goat anti-rabbit IgG-Cy3 (1:2000; Amersham Biosciences, Piscataway, NJ) in blocking solution for 2 hr, and (5) PBS, six times for 5 min each. Characterization of the specificity of the 16153 Na v 1.3 antibody has been performed in previous studies (Hains et al., 2002 (Hains et al., , 2003c . To further categorize cells that express Na v 1.3, we used the guinea pig antisubstance-P receptor neurokinin-1 receptor (NK1R) (1:250; Affiniti Research Products Ltd., Exeter, UK), mouse anti-GFAP (1:250; Chemicon, Temecula, CA), and mouse anti-OX-42 CD11b/c (1:250; BD Biosciences, San Jose, CA) primary antibodies. Secondary antibodies included goat anti-rabbit Cy3 (1:2000; Amersham Biosciences), goat anti-mouse Alexa 488 (1:1000; Molecular Probes, Eugene, OR), and goat anti-guinea pig Cy2 (1:250; Rockland Immunochemicals, Gilbertsville, PA). Control experiments were performed without primary or secondary antibodies, yielding only background levels of signal.
Quantitative image analysis. Images were captured with a Nikon (Melville, NY) Eclipse E800 light microscope equipped with epifluorescence and Nomarski optics, using a SPOT RT camera (Diagnostic Instruments Inc., Sterling Heights, MI). Quantitative analysis was performed by a blinded observer using IPLab Spectrum software (Scanalytics, Fairfax, VA), and the number of positively labeled neurons was counted for each dorsal horn. Cells were sampled only if the nucleus was visible within the plane of section and if cell profiles exhibited distinctly delineated borders. Background levels of signal were subtracted, and control and experimental conditions were evaluated in an identical manner.
Electrophysiological procedures. Ten days after CCI or sham surgery, animals (n ϭ 4/group; each yielding 7-12 units ipsilateral or contralateral to the injury site per group) underwent extracellular single-unit recording as described by Hains et al. (2003a,b) . Rats were anesthetized with halothane by tracheal intubation (1.1%; 2-2.5 cc tidal volume; 60 -70 strokes/min). Rectal temperature was maintained at 37°C. Units were isolated from L3-L5 medially near the dorsal root entry zone up to a depth of 1000 m. Recordings were made with a low-impedance 5 M⍀ tungsten-insulated microelectrode (A-M Systems, Carlsborg, WA) after a cell was identified and its receptive field was mapped. Three routine mechanical stimuli were applied: (1) brush (BR) stimulation of the skin with a cotton applicator, (2) pressure (PR), by attaching a large arterial clip with a weak grip to a fold of the skin (144 gm/mm 2 ), and (3) pinch (PI), by applying a small arterial clip with a strong grip to a fold of skin (583 gm/mm 2 ). Multireceptive (MR) neurons were identified by their relative magnitude of responsiveness to all stimuli, criteria that were used in all groups to ensure recording of MR neurons. Because phenotype shifts can occur after CCI, such that more neurons could assume a MR functional classification, our search paradigm ensured that in all groups we sampled MR neurons. Stimulation was applied with the experimenter blinded to the output of the cell during stimulation. Background activity was recorded for 20 sec, and stimuli were applied serially for 20 sec, separated by another 20 sec of spontaneous activity without stimulation. Care was taken to ensure that the responses were maximal, that each stimulus was applied to the primary receptive field of the cell, and that isolated units remained intact for the duration of each experiment using Spike2 template-matching routines. Neurons were considered to be hyperresponsive if evoked frequencies were Ͼ150% of control levels.
Electrical signals were amplified and filtered at 300 -3000 Hz (DAM80; World Precision Instruments, Sarasota, FL), processed by a datacollection system (CED Micro1401; Cambridge Electronic Design, Cambridge, UK), and stored on a computer (Pentium 4 personal computer; Dell, Austin, TX) to construct peristimulus time histograms or wavemark files. The stored digital record of individual unit activity was retrieved and analyzed off-line with Spike2 software, version 3.13 (Cambridge Electronic Design).
Behavioral testing. Behavioral analysis (n ϭ 8 -10 animals/group) was performed daily from day 10 to day 17 after CCI. After acclimation to the testing area (30 min), mechanical sensory thresholds were determined by paw withdrawal to application of a series of von Frey filaments (Stoelting, Wood Dale, IL) to the glabrous surface of the paw. After application of calibrated von Frey filaments (0.4 -26 gm, verified by calibration against a force transducer) with enough force to cause buckling of the filament, a modification of the "up-down" method of Dixon (1980) was used to determine the value at which paw withdrawal occurred 50% of the time (Chaplan et al., 1994) , which was interpreted to be the mechanical nociceptive threshold.
After acclimation to the test chamber, thermal hyperalgesia was assessed by measuring the latency of paw withdrawal in response to a radiant heat source (Dirig et al., 1997) . Animals were placed in Plexiglas boxes on an elevated glass plate, under which a radiant heat source (4.7 A) was applied to the glabrous surface of the paw through the glass plate. The heat source was turned off automatically by a photocell when the limb was lifted, allowing the measurement of paw-withdrawal latency. Three minutes were allowed between each trial, and four trials were averaged for each limb.
Statistical analysis. All statistical tests were performed at the ␣ level of significance of 0.05 by two-tailed analyses using parametric tests. Data were tested for significance using one-way ANOVA, followed by Bonferroni post hoc analysis. Tests of factors including pairwise comparisons were applied with either the paired Student's t test or the two-sample Student's t test. Data management and statistical analyses were performed using SAS (1992) statistical procedures with SigmaStat (version 1.0; Jandel Scientific, Corte Madera, CA) and graphed as mean Ϯ SD using Jandel SigmaPlot (version 7.0).
Results

In situ hybridization
In situ Na v 1.3 mRNA hybridization studies were performed on lumbar spinal cord sections 10 d after CCI (Fig. 1) . Sections from intact animals (Fig. 1 A) and from the contralateral side (data not shown) showed very little hybridization signal for Na v 1.3. After CCI, Na v 1.3 hybridization signal was clearly present on the ipsilateral side within small (5-10 m) neurons in laminas I-II, in addition to larger (20 -40 m) neurons in laminas III-IV (Fig.  1 B) . Neurons expressing Na v 1.3 were localized in the medial aspect of the dorsal horn, which is known to be the predominant projection territory of somatosensory afferents with receptive fields on the hindlimbs/paws. Quantification by densitometry (Fig. 1C) showed the ipsilateral increase in Na v 1.3 signal to be statistically significant ( p Ͻ 0.05). No Na v 1.3 signal was observed in afferent fibers or in dendritic and/or axonal arborizations, and no signal was detected within white-matter tracts. Na v 1.3 hybridization signal was not observed in the DRG contralateral to the CCI (Fig. 1 E) , but signal was present on the ipsilateral side (Fig.  1 F) in small-and large-diameter DRG neurons.
The change in Na v 1.3 mRNA, measured by quantitative reverse transcription (RT)-PCR amplification from the DRG and lumbar enlargement of sham-operated and CCI groups, is shown in Figure 1 D. Quantitative RT-PCR results showed a statistically significant increase in the ipsilateral DRG to ϳ183% of the contralateral side after CCI. In lumbar dorsal horn ipsilateral to CCI mRNA was increased to ϳ158% of sham-operated Na v 1.3 mRNA levels. No significant changes were observed on the side contralateral to the CCI in either the DRG or lumbar enlargement. 
Immunocytochemistry
Immunocytochemistry with an isoform-specific antibody raised against Na v 1.3 revealed very little expression of Na v 1.3 in the lumbar dorsal horn of the contralateral spinal cord after CCI (Fig.  2 A) and in sham-operated intact animals (data not shown). Ten days after CCI, however, expression of Na v 1.3 was clearly increased in the ipsilateral dorsal horn (Fig. 2 B) . Na v 1.3 signal was observed in dorsal horn cells exhibiting multipolar neuronal profiles in laminas I-IV, and the distribution was increased in neurons located medially in these laminas.
Staining for NK1R, which provides a marker for nociceptive neurons, demonstrated a distribution of NK1R-positive dorsal horn neurons consistent with previous reports (Ishigooka et al., 2001), with signal detected in dorsal horn laminas I-VI. After CCI, colocalization with Na v 1.3 revealed that ipsilateral dorsal horn neurons expressing Na v 1.3 were also positive for NK1R (Fig.  2 B) . In immunocytochemistry reactions in which primary antibody (16153, 3-1) was omitted (Fig. 2C) , no Na v 1.3 signal was detectable.
Increased signal for Na v 1.3 was observed in the ipsilateral DRG (Fig. 2 E) , compared with the contralateral side of CCI animals (Fig. 2 D) and sham-operated animals (data not shown).
Double-labeling experiments revealed that, in the ipsilateral dorsal horn after CCI, Na v 1.3 protein did not colocalize with OX-42, a marker for microglia (Fig.  3A-C) , or with GFAP, a marker for astrocytes (Fig. 3D-F ) .
Extracellular unit recordings
Units were sampled from dorsal horn laminas I-V (24 -988 m). Representative peristimulus time histograms (spikes/1 sec bin) are shown in Figure 4 for MR neurons in sham-operated control animals (Fig. 4 A) and the ipsilateral side of CCI groups 10 d after injury (Fig.  4 B) . When compared with controls, CCI animals showed increased evoked activity to all peripheral stimuli (brush, pressure, pinch) on the ipsilateral side. After CCI, spontaneous background activity was elevated (Fig. 4 B) . Of 33 MR neurons sampled in CCI animals, 78% (26 of 33) were hyperresponsive.
Quantification of mean Ϯ SD evoked discharge rates of MR neurons, over background, from sham-operated and CCI groups is shown in see Figure 7C . Responses were typical for MR neurons, demonstrating high evoked activity to all stimuli. Compared with sham-operated animals that demonstrated evoked response rates between 5 and 15 Hz, CCI animals demonstrated significantly increased response rates of up to 20 -60 Hz.
Antisense knockdown of Na v 1.3
Because our results showed upregulated Na v 1.3 expression, hyperresponsiveness of dorsal horn sensory neurons, and allodynia and hyperalgesia, we then asked whether targeted ODN knockdown of Na v 1.3 after CCI would reduce dorsal horn neuronal hyperresponsiveness and ameliorate painrelated behaviors. In these experiments we intrathecally administered Na v 1.3 AS, as well as its mismatch sequence, beginning on day 11 after injury.
A single injection (5 l) of Cy3-labeled AS diffused to a depth of 800 -900 m in spinal parenchyma and was taken up by cells exhibiting a neuronal morphology as deep as lamina V (Fig. 5A) . In contrast to its robust penetration into the spinal cord, Cy3-labeled AS was unable to penetrate DRG neurons (Fig. 5B) , a result similar to our previous findings (Hains et al., 2003c) . Neither Na v 1.3 MM (Fig. 5C) nor AS (Fig. 5D ) administration was Immunocytochemical localization of Na v 1.3 (red channel) and substance-P receptor (NK1R, green channel) protein within the ipsilateral and contralateral dorsal horn 10 d after CCI. A, On the contralateral side, very few Na v 1.3 immunopositive profiles were detectable, whereas NK1R signal was present in cells exhibiting neuronal morphologies throughout all dorsal horn laminas. Inset, High-magnification of double-labeled neuron. B, On the side ipsilateral to CCI, Na v 1.3 and NK1R positively labeled cell profiles were observed throughout laminas I-V. Merged images show colocalization of Na v 1.3 and NK1R (yellow) within ipsilateral dorsal horn after CCI ( B). C, In reactions for which primary antibody (16153) was omitted, no Na v 1.3 signal was detectable. Increased signal for Na v 1.3 was observed in the ipsilateral DRG ( E) compared with the contralateral side of CCI animals ( D). Na v 1.3 AS reduced Na v 1.3 but not NK1R signal in the ipsilateral dorsal horn after CCI (data not shown) ( Table 1) . Scale bar, 300 m. CONT, Contralateral; IPSI, ipsilateral.
effective in knocking down Na v 1.3 mRNA expression in ipsilateral DRG neurons after CCI.
To show that administration of Na v 1.3 AS into the spinal cord in fact resulted in knockdown of Na v 1.3, we assessed its effect on Na v 1.3 mRNA and immunoreactivity. In situ hybridization demonstrated that Na v 1.3 MM administration after CCI had no effect on Na v 1.3 mRNA signal (Fig.  6 A) , whereas administration of Na v 1.3 AS for 4 d resulted in significantly decreased Na v 1.3 signal in the ipsilateral dorsal horn (Fig. 6 B) . When measured by RT-PCR 4 d after Na v 1.3 AS administration, levels of Na v 1.3 mRNA were significantly decreased in the ipsilateral dorsal horn, falling to ϳ115% of intact levels (Fig. 6C) , whereas after MM administration, Na v 1.3 mRNA levels remained elevated at 160% of intact levels.
Immunostaining for Na v 1.3 revealed a loss of Na v 1.3 immunoreactivity in AStreated CCI compared with untreated or MM CCI. Quantification (Table 1) revealed that AS but not MM significantly reduced the number of NK1R-positive neurons that express Na v 1.3.
Unit recordings showed that knockdown of Na v 1.3 resulted in decreased hyperresponsiveness of dorsal horn neurons. Four days after administration of Na v 1.3 AS (Fig. 7B ), but not after administration of MM (Fig. 7A) , hyperresponsiveness of MR neurons was reduced in the ipsilateral dorsal horn of CCI rats. Quantification revealed that Na v 1.3 AS treatment significantly reduced evoked hyperresponsiveness of dorsal horn neurons (Fig. 7C ).
Behavioral testing
By 10 d after CCI, animals developed mechanical allodynia, as demonstrated by decreases in paw-withdrawal thresholds to von Frey stimulation (Fig. 8 A) . Mean Ϯ SD mechanical thresholds were significantly decreased on the side ipsilateral to the CCI (3.3 Ϯ 1.5 gm) compared with the contralateral side (23.0 Ϯ 2.0 gm), with a mean ipsilateral versus a contralateral difference score of 19.7 Ϯ 1.7 gm for all CCI animals. Thermal behavioral testing revealed that by 10 d after CCI, animals developed thermal hyperalgesia, as indicated by decreases in paw-withdrawal latency (Fig. 8 B) . In the injured animals, the mean difference score between ipsilateral (withdrawal latency, 6.21 Ϯ 1.19 sec) and contralateral (withdrawal latency, 9.74 Ϯ 1.09 sec) limbs was 3.53 Ϯ 1.14 sec at this time point.
Administration of Na v 1.3 AS starting on day 11 decreased the mechanical allodynia and resulted in an increase in the withdrawal threshold and a reduction of the difference score between ipsilateral and contralateral limbs (Fig. 8 A) . By day 4 of Na v 1.3 AS administration, the ipsilateral (withdrawal threshold, 17.4 Ϯ 4.9) and contralateral (withdrawal threshold, 21.0 Ϯ 1.6) difference score was reduced to 3.6 Ϯ 3.3 gm. Three days after cessation of AS administration (day 17), allodynia was restored to pre-AS levels in these animals (difference score, 18.2 Ϯ 5.6). Administration of MM had no effect on CCI animals (difference score remained at 20.1 Ϯ 1.7), and AS had no effect on intact animals (data not shown). Na v 1.3 AS administration decreased thermal hyperalgesia and reduced the difference score to 0.15 Ϯ 1.52 sec (withdrawal latencies: ipsilateral, 10.23 Ϯ 1.49 sec; contralateral, 10.38 Ϯ 1.56 sec) by day 4 of administration ( Fig. 8 B) . Three days after AS withdrawal, thermal hyperalgesia reappeared and the difference score for ipsilateral (withdrawal latency, 6.61 Ϯ 0.95 sec) and contralateral (withdrawal latency, 10.61 Ϯ 0.88 sec) sides was restored to 3.99 Ϯ 0.91 sec. No effects were observed in CCI animals receiving MM (difference score, 3.75 Ϯ 1.01 sec) or in uninjured animals receiving AS (data not shown).
Discussion
In the present study, we show for the first time that after peripheral nerve injury, the expression of the voltage-gated sodium channel Na v 1.3 is upregulated in higher-order sensory (dorsal horn) neurons. Because these results suggest an association between Na v 1.3 upregulation, hyperresponsiveness of dorsal horn sensory neurons, and neuropathic pain, we used a selective antisense strategy to show that targeted knockdown of Na v 1.3 results in downregulation of Na v 1.3 mRNA and protein, reduction in hyperresponsiveness of dorsal horn neurons, and reversal of pain-related behaviors after injury.
There may be many possible explanations for the increases in spontaneous and evoked firing of MR neurons after injury, including presynaptic and local network alterations after CCI. Our results strongly suggest that the increased neuronal responsiveness is attributable, at least in part, to sodium channel upregulation. After injury to their axons, first-order spinal sensory neurons (DRG neurons) demonstrate increased sodium conductance, which has been associated with increased expression of voltage-gated sodium channels (Devor et al., 1989; Matzner and Devor, 1994; Rizzo et al., 1995; Cummins and Waxman, 1997; Zhang et al., 1997; Novakovic et al., 1998; Black et al., 1999) , implicating a link between sodium channel activity within DRG neurons and hyperresponsiveness of these neurons associated with pain. Consistent with this, experimental and clinical observations have demonstrated partial efficacy of sodium channel blocking agents in neuropathic pain (Chabal et al., 1989; Devor et al., 1992; Omana-Zapata et al., 1997; Rizzo, 1997) ,
Spinal expression of Na v 1.3 is detectable at embryonic day 17 and postnatal day 2 (P2) but is downregulated with further development, exhibiting very low levels of expression by P30 (Beckh et al., 1989; Felts et al., 1997) . Upregulation of Na v 1.3 is functionally important because, Na v 1.3 recovers (reprimes) rapidly from inactivation, a property that poises neurons to produce highfrequency activity (Cummins and Waxman, 1997; Black et al., 1999; Cummins et al., 2001 ). Increased expression of Na v 1.3 occurs in DRG neurons after injury to the sciatic nerve (Waxman et al., 1994; DibHajj et al., 1996; Black et al., 1999; Kim et al., 2001 ) and in facial motor neurons after transection of the facial nerve (Iwahashi et al., 1994) , but expression of Na v 1.3 is not increased in spirally axotomized cortical pyramidal neurons (Hains et al., 2002) . Upregulation of Na v 1.3 expression in DRG neurons is associated with allodynia and hyperalgesia (Dib-Hajj et al., 1999) . Recently, we showed that Na v 1.3 expression is upregulated in dorsal horn neurons after spinal cord contusion injury, and that Na v 1.3 AS reduces neuronal hyperresponsiveness and pain-related behaviors (Hains et al., 2003c) .
Increased firing activity of dorsal horn neurons after peripheral nerve injury could be driven at several sites. First, as early as 3 d after injury, ectopic discharges and abnormal responses to stimuli originate in the injured axons and their cells of origin within the DRG (Wall and Gutnick, 1974; Govrin-Lippmann and Devor, 1978; Scadding, 1981; Wall and Devor, 1983; Kajander et al., 1992; Kral et al., 1999) and are expected to drive dorsal horn neurons to relay higher-frequency afferent information supraspinally. Second, dorsal horn neurons undergo reactive changes that make them hyperresponsive, and abnormal firing has been shown to originate from within the dorsal horn after peripheral injury (Basbaum and Wall, 1976; Woolf, 1983; Woolf and Wall, 1986; Palecek et al., 1992; Sotgiu et al., 1992; Laird and Bennett, 1993) . Activity-dependent central sensitization (heterosynaptic facilitation) is evident within seconds of a nociceptive conditioning stimulus and can outlast the stimulus for hours (Woolf and Wall, 1986) . Within the dorsal horn, increases in excitatory amino acid concentrations (Somers et al., 2002) and reduction of GABA concentrations (Ibuki et al., 1997; Stiller et al., 1996) may also contribute to allodynia and hyperalgesia after nerve injury. The present results also suggest that upregulated expression of Na v 1.3 contributes to hyperresponsiveness of these central neurons after nerve injury. We cannot rule out a contribution of other species of voltage-gated sodium channel isoforms that could effect firing thresholds, however.
We have shown previously (Hains et al., 2003c ) that intrathecal administration of Na v 1.3 knocks down Na v 1.3 expression within dorsal horn neurons, but not within DRG neurons, after SCI, and we confirm this observation in the present study. Lack of penetration of Cy3-labeled AS into the DRG (in contrast to its clear penetration into the dorsal horn) may be attributable to differences in ensheathment that limit access to DRG neurons. Although it might be argued that upregulated Na v 1.3 expression within dorsal horn neurons could be a response to highfrequency firing in nociceptive pathways after nerve injury, our results demonstrate the opposite (i.e., that high-frequency firing is attenuated when Na v 1.3 is knocked down in these neurons). Our observation, in the present study, of reduced pain-related behaviors and reduced hyperresponsiveness during Na v 1.3 AS administration as well as return of pain-related behaviors when A, Mean Ϯ SD von Frey (VF) filament threshold values, displayed as the difference between ipsilateral and contralateral paw thresholds, show that by 10 d after CCI, paw-withdrawal thresholds were significantly decreased on the ipsilateral side compared with the contralateral side and sham-operated controls. Intrathecal administration (indicated by gray shading) of Na v 1.3 MM had no effect on mechanical thresholds, whereas Na v 1.3 AS resulted in a significant (*p Ͻ 0.05) reduction in mechanical allodynia. After cessation of AS administration, mechanical thresholds returned to levels consistent with CCI. B, Mean Ϯ SD paw-withdrawal latency (in seconds) to radiant thermal stimuli after CCI demonstrates decreased latencies and development of thermal hyperalgesia ipsilaterally by 10 d after CCI. In sham-operated animals, no differences in paw-withdrawal latency were observed. Administration of Na v 1.3 MM had no effect on withdrawal latency, whereas administration of Na v 1.3 AS resulted in withdrawal latencies that were significantly (*p Ͻ 0.05) increased in the ipsilateral paw. Cessation of AS administration resulted in restoration of thermal hyperalgesia. 
